SEC Filing Summary: Bristol-Myers Squibb Co. (8-K)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Bristol-Myers Squibb Company on February 14, 2007, regarding an event that occurred on February 9, 2007. The filing addresses corporate governance matters concerning the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. Vance D. Coffman notified the company that he will not stand for re-election to the Board of Directors at the 2007 Annual Meeting of Stockholders, expected to be held on May 1, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the director's departure.
Key Facts for Investor Verification
- Vance D. Coffman will not seek re-election to the Board of Directors.
- The 2007 Annual Meeting of Stockholders is expected to be held on May 1, 2007.
- No financial data or operational updates are included in this specific filing.